Stock Events

Enovis 

R$64.44
0
+R$0+0% Thursday 15:41

Statistics

Day High
69.63
Day Low
64.44
52W High
80.96
52W Low
64.44
Volume
8
Avg. Volume
3
Mkt Cap
-
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

21FebExpected
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Next
0.37
0.49
0.6
0.72
Expected EPS
0.71
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow E2NO34.SA. It's not an investment recommendation.

About

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
Show more...
CEO
Mr. Mitchell P. Rales
Employees
16200
Country
United States
ISIN
BRE2NOBDR001

Listings